Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1111-1120 of 9364

Page
per page
  1. VE-821
    A2521 VE-821
     2 Citation
    Summary: ATR kinase inhibitor
      ≥62.5 mg/mL
  2. Tyrphostin AG 1296
    A2477 Tyrphostin AG 1296
     1 Citation
    Target: PDGFR
    Summary: PDGFR inhibitor,selective and ATP-competitive
  3. VU 0364439
    A2623 VU 0364439
    Summary: Positive allosteric mGluR-4 modulator
      ≥21.11 mg/mL
  4. AMG-517
    A1174 AMG-517
    Target: TRP Channel
    Summary: TRPV1 antagonist,potent and highly selective
      ≥21.5 mg/mL
  5. AZD5363
    A1387 AZD5363
     6 Citation
    Target: Akt
    Summary: AKT inhibitor,pyrrolopyrimidine derived
      ≥21.45 mg/mL
  6. Butein
    A2689 Butein
    Target: Src|STAT|EGFR|Angiotensin-Converting Enzymes (ACEs)|5-Lipoxygenases|PTK|enoyl-acyl-carrier protein reductase
    Summary: Protein kinase inhibitor
      insoluble in H2O; ≥13.6 mg/mL
  7. CEP-32496
    A1413 CEP-32496
    Summary: BRAF(V600E)inhibitor,highly potent
      ≥25.85 mg/mL
  8. Macitentan
    A1929 Macitentan
    Summary: Endothelin (ET)(A) and ET(B) receptor antagonist
      ≥24.4 mg/mL
  9. SC 144
    A2173 SC 144
     1 Citation
    Target: Glycoproteins
    Summary: Gp130 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥16.1 mg/mL
  10. Nutlin-3b
    A2005 Nutlin-3b
    Target: p53-MDM2 interaction
    Summary: MDM2/p53 inhibitor

Items 1111-1120 of 9364

Page
per page